Mostra i principali dati dell'item

dc.creatorPapaevangelou V., Alexopoulou Z., Hadjichristodoulou C., Kourlamba G., Katsioulis A., Theodoridou K., Spoulou V., Theodoridou M.en
dc.date.accessioned2023-01-31T09:42:52Z
dc.date.available2023-01-31T09:42:52Z
dc.date.issued2016
dc.identifier10.1080/21645515.2016.1151589
dc.identifier.issn21645515
dc.identifier.urihttp://hdl.handle.net/11615/77651
dc.description.abstractABSTRACT: Hepatitis A vaccine was introduced in the Greek National Immunization Program in 2008. To estimate possible impact of the universal vaccination implementation, time trends of hospitalizations for hepatitis A at the Infectious Diseases Unit of a Tertiary Pediatric Hospital in Athens during 1999–2013 were analyzed. Hepatitis A hospitalizations were recorded from the discharge database and were expressed as frequencies and rate of annual departmental hospitalizations. Time series analysis (ARIMA) was used to explore trends and the impact of the vaccination. Moreover, changes in patient age, population group distribution and the duration of hospitalization were also examined. Hepatitis A hospitalizations rate significantly decreased between pre-vaccination (1999–2008) and post-vaccination (2009–2013) era from 50.5 to 20.8/1000 hospitalizations (p = 0.005). A 3-year periodicity and a trend of reduction on hepatitis A hospitalizations rates across years were noted. Roma children had significant higher rates of hepatitis A hospitalization, followed by immigrant children. Importantly, possibly due to preceding vaccine availability with considerable uptake in private market and unvaccinated group/pockets of children (Roma), overall vaccination effect was less apparent when compared to data from other countries that implemented universal vaccination. No significant change in patient age, population group distribution, or duration of hospitalization was observed. High risk groups such as Roma children should be targeted for vaccination to reduce future outbreaks. © 2016 Taylor & Francis.en
dc.language.isoenen
dc.sourceHuman Vaccines and Immunotherapeuticsen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84965017097&doi=10.1080%2f21645515.2016.1151589&partnerID=40&md5=cc8e6f31afd740740260137279965aa4
dc.subjecthepatitis A vaccineen
dc.subjecthepatitis A vaccineen
dc.subjectadolescenten
dc.subjectArticleen
dc.subjectchilden
dc.subjectchild hospitalizationen
dc.subjecthepatitis Aen
dc.subjecthigh risk populationen
dc.subjecthospital admissionen
dc.subjecthumanen
dc.subjectimmigranten
dc.subjectinfanten
dc.subjectmajor clinical studyen
dc.subjectnewbornen
dc.subjectretrospective studyen
dc.subjecttrend studyen
dc.subjectvaccinationen
dc.subjectfemaleen
dc.subjectGreeceen
dc.subjecthealth care policyen
dc.subjecthepatitis Aen
dc.subjecthospitalizationen
dc.subjectincidenceen
dc.subjectmaleen
dc.subjectpreschool childen
dc.subjectpreventive health serviceen
dc.subjecttime factoren
dc.subjectAdolescenten
dc.subjectChilden
dc.subjectChild, Preschoolen
dc.subjectFemaleen
dc.subjectGreeceen
dc.subjectHealth Policyen
dc.subjectHepatitis Aen
dc.subjectHepatitis A Vaccinesen
dc.subjectHospitalizationen
dc.subjectHumansen
dc.subjectImmunization Programsen
dc.subjectIncidenceen
dc.subjectInfanten
dc.subjectInfant, Newbornen
dc.subjectMaleen
dc.subjectRetrospective Studiesen
dc.subjectTime Factorsen
dc.subjectTaylor and Francis Inc.en
dc.titleTime trends in pediatric hospitalizations for hepatitis A in Greece (1999–2013): Assessment of the impact of universal infant immunization in 2008en
dc.typejournalArticleen


Files in questo item

FilesDimensioneFormatoMostra

Nessun files in questo item.

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item